|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Sales expenses | |||||
| General and administrative expenses | |||||
| Other operating expenses, net | |||||
| Settlement of founder's royalty option | |||||
| Stock-based compensation | |||||
| Operating expenses | |||||
| Operating loss before financial results and income taxes | |||||
| Financial expenses, net | |||||
| Depreciation | |||||
| Loss before income tax and social contribution | |||||
| Income tax and social contribution – current | |||||
| Income tax and social contribution – deferred | |||||
| Net loss for the year | |||||
| Foreign exchange loss (gain) loss | |||||
| Cumulative translation adjustment | |||||
| Net loss and comprehensive loss for the period | |||||
| Basic net loss per common share | |||||
| Diluted net loss per common share | |||||
| Weighted average number of common shares outstanding - basic | |||||
| Weighted average number of common shares outstanding - diluted | |||||
Loading...